1. 1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis. (31st December 2020) Authors: Eron, Joseph J; Wilkin, Aimee; Ramgopal, Moti; Osiyemi, Olayemi; McKellar, Mehri; McKellar, Mehri; Slim, Jihad; Asmuth, David; DeJesus, Edwin; German, Polina; Blair, Christiana; Carter, Christoph C; Brainard, Diana M; Collins, Sean E; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine. (31st December 2020) Authors: Brar, Indira; Ruane, Peter; Ward, Douglas; Molina, Jean-michel; Mills, Anthony; Berhe, Mezgebe; Brinson, Cynthia; Rampogal, Moti; Benson, Paul; Henry, Keith; Huang, Hailin; Andreatta, Kristen; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV. (31st December 2020) Authors: Hagins, Debbie; Kumar, Princy; Saag, Michael; Wurapa, Anson K; Brar, Indira; Berger, Daniel; Osiyemi, Olayemi; Hileman, Corrilynn; Ramgopal, Moti; McDonald, Cheryl; Blair, Christiana; Andreatta, Kristen; Collins, Sean E; Brainard, Diana M; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two Phase 3 randomized clinical trials. (15th December 2022) Authors: Ramgopal, Moti; Wurapa, Anson; Baumgarten, Axel; Berhe, Mezgebe; Pozniak, Anton; Orkin, Chloe; Tiraboschi, Juan Manuel; Hagins, Debbie P; Huang, Hailin; Andreatta, Kristin; Unger, Nathan; Hindman, Jason; Martin, Hal; Baeten, Jared; Osiyemi, Olayemi Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 69. Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks. (4th December 2021) Authors: Daar, Eric; Orkin, Chloe; Sax, Paul; Stephens, Jeffrey L; Koenig, Ellen; Clarke, Amanda; Baumgarten, Axel; Brinson, Cynthia; Ramgopal, Moti; Huang, Hailin; Farrow, Terry; Baeten, Jared; Hindman, Jason; Martin, Hal; Workowski, Kimberly Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 69. Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks. (4th December 2021) Authors: Daar, Eric; Orkin, Chloe; Sax, Paul; Stephens, Jeffrey L; Koenig, Ellen; Clarke, Amanda; Baumgarten, Axel; Brinson, Cynthia; Ramgopal, Moti; Huang, Hailin; Farrow, Terry; Baeten, Jared; Hindman, Jason; Martin, Hal; Workowski, Kimberly Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Randomized Trial of Bictegravir or Dolutegravir with Emtricitabine and Tenofovir Alafenamide (F/TAF) Followed by Open Label Switch to Bictegravir/F/TAF Fixed Dose Combination. (4th October 2017) Authors: Sax, Paul E; Dejesus, Edwin; Crofoot, Gordon; Ward, Douglas; Benson, Paul; Wei, Lilian; White, Kirsten; Collins, Sean; Martin, Hal; Cheng, Andrew; Quirk, Erin Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults. (1st May 2017) Authors: Gallant, Joel E.; Thompson, Melanie; DeJesus, Edwin; Voskuhl, Gene W.; Wei, Xuelian; Zhang, Heather; White, Kirsten; Cheng, Andrew; Quirk, Erin; Martin, Hal Journal: Journal of acquired immune deficiency syndromes Issue: Volume 75:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Issue 6 (June 2019) Authors: Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie A; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti N; Antinori, Andrea; Wei, Xuelian; Acosta, Rima; Collins, Sean E; Brainard, Diana; Martin, Hal Journal: Lancet Issue: Volume 6:Issue 6(2019) Page Start: e355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial. Issue 4 (April 2017) Authors: Sax, Paul E; DeJesus, Edwin; Crofoot, Gordon; Ward, Douglas; Benson, Paul; Dretler, Robin; Mills, Anthony; Brinson, Cynthia; Peloquin, Julie; Wei, Xuelian; White, Kirsten; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Lancet Issue: Volume 4:Issue 4(2017) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗